Certuity’s 10x Genomics TXG Stock Holding History

Certuity’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$656K	Buy	30,906 +10,702	+53%	+$214K	0.04%	231
2025 Q4	$330K	Buy	20,204 +904	+5%	+$13.7K	0.02%	386
2025 Q3	$226K	Buy	+19,300	New	+$252K	0.02%	491

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Certuity's TXG Position: Q1 2026 in Review

Certuity increased its 10x Genomics (TXG) stake by 53% in Q1 2026, buying an estimated $214K and bringing the position to 30,906 shares worth $656K. The position accounts for 0.04% of the portfolio, ranked #231.

Certuity first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Certuity held 30,906 shares of 10x Genomics worth $656K as of Q1 2026.
Certuity bought 10,702 10x Genomics shares in Q1 2026, an estimated $214K.
10x Genomics made up 0.04% of Certuity's portfolio in Q1 2026, its #231 holding.
Certuity first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.